Key facts
- This page summarizes David Mulham Mulham's Form 4 filing for USANA HEALTH SCIENCES INC (USNA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Dec 2025, 11:25.
David Mulham Mulham - 10 Dec 2025 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)
- Reporting relationship
- CHIEF SALES OFFICER
- Issuer ticker
- USNA
- Reported as of
- 10 Dec 2025
- Net transaction value
- -$18,333
- SEC form
- 4
- Accepted by SEC
- 11 Dec 2025, 11:25:25 UTC
- Prior SEC filing
- 31 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joshua Foukas, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David Mulham Mulham filed Form 4 for USANA HEALTH SCIENCES INC (USNA) on 11 Dec 2025.
Change
- Previous filing in this sequence was filed on 31 Jul 2025.
- Current net transaction value: -$18,333.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001697433
Primary reporting owner
Mulham David Mulham
- Relationship
- CHIEF SALES OFFICER
- Address
- 3838 WEST PARKWAY BLVD, SALT LAKE CITY
- Signature
- /s/ Joshua Foukas, Attorney-in-Fact
- Signature date
- 11 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
USNA
transaction
Common Stock
Sale
- Transaction value
- $18,333
- Shares
- -873
- Change %
- -9.4%
- Price
- $21.00
- Shares after
- 8,387
- Date
- 10 Dec 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.